A clinical study on risk behaviors and seroprevalence of HIV, hepatitis B, and hepatitis C among injection drug users on opioid substitution therapy: An observational study

A clinical study on risk behaviors and seroprevalence of HIV, hepatitis B, and hepatitis C among injection drug users on opioid substitution therapy: An observational study

Introduction: Hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV infection among IDUs is an emerging trend. Opioid substitution therapy (OST) is an evidence-based treatment for opiate-dependent clients that replaces illicit drug use with medically prescribed, orally administered opiates such...

Full description

Bibliographic Details
Main Authors:	Shabir Ahmad Dar, Bilal Ahmad Bhat, Aaliya Khanam, Shazia Kousar
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Indian Journal of Social Psychiatry
Subjects:	buprenorphine injection drug users opioids
Online Access:	http://www.indjsp.org/article.asp?issn=0971-9962;year=2020;volume=36;issue=2;spage=146;epage=150;aulast=Dar

Similar Items

Does buprenorphine maintenance improve the quality of life of opioid users?
by: A Dhawan, et al.
Published: (2013-01-01)

Intravenous buprenorphine does not impair psychomotor and cognitive functioning in opioid-dependent patients using oral dextropropoxyphene: A randomized, double-blind, crossover study
by: Shri Gopal Goyal, et al.
Published: (2020-01-01)

Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation
by: Ling W, et al.
Published: (2019-11-01)

Depot Buprenorphine Injection in the Management of Opioid Use Disorder: From Development to Implementation [Corrigendum]
by: Ling W, et al.
Published: (2020-01-01)

Budget Impact Analysis of the Introduction of Injectable Prolonged-Release Buprenorphine on Opioid Use Disorder Care Resource Requirements
by: Phillips-Jackson H, et al.
Published: (2020-05-01)

Family burden in injecting versus noninjecting opioid users
by: Naresh Nebhinani, et al.
Published: (2013-01-01)

Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations
by: Joanne Neale, et al.
Published: (2019-04-01)

Single high-dose buprenorphine for opioid craving during withdrawal
by: Jamshid Ahmadi, et al.
Published: (2018-12-01)

Challenges in implementing opioid agonist therapy in Lebanon: a qualitative study from a user’s perspective
by: Ali Ghaddar, et al.
Published: (2018-04-01)

The relationship of suicide attempt story and stress coping style among the patients with opioid substitution therapy
by: Vahap Karabulut, et al.
Published: (2018-09-01)

Anxiety treatment of opioid dependent patients with buprenorphine: A randomized, double-blind, clinical trial
by: Jamshid Ahmadi, et al.
Published: (2017-01-01)

Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities
by: Björn Johnson, et al.
Published: (2019-05-01)

A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department
by: David Wiercigroch, et al.
Published: (2021-04-01)

Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco
by: Jamie Carter, et al.
Published: (2019-05-01)

Addiction Recovery Among Opioid-Dependent Patients Treated With Injectable Subcutaneous Depot Buprenorphine: Study Protocol of a Non-randomized Prospective Observational Study (ARIDE)
by: Bernd Schulte, et al.
Published: (2020-12-01)

Opioid Replacement for Pregnant Mothers With Opioid Use Disorder and Fetal Neurodevelopment: A Review
by: Caragh Dallas Miller, et al.
Published: (2017-12-01)

Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals
by: Webster LR, et al.
Published: (2016-06-01)

Prescribing Buprenorphine for Opioid Use Disorders in the ED: A Review of Best Practices, Barriers, and Future Directions
by: Cao SS, et al.
Published: (2020-10-01)

Collaborative Video Consultations from Tertiary Care Based Telepsychiatrist to a Remote Primary Care Doctor to Manage Opioid Substitution Therapy Clinic
by: Erika Pahuja, et al.
Published: (2020-06-01)

Opioid withdrawal presenting as delirium and role of buprenorphine: A case series
by: Sourav Das, et al.
Published: (2017-01-01)

Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment
by: Jens Reimer, et al.
Published: (2019-12-01)

Chronic Pain Opioid-Maintained Patients Receive Less Analgesic Opioid Prescriptions
by: Jessica Delorme, et al.
Published: (2018-07-01)

A clinical study of opioid substitution therapy in a tertiary care center of Eastern India
by: Satyakam Mohapatra, et al.
Published: (2017-01-01)

Long-term agonist and antagonist therapy for adolescent opioid dependence: A description of two cases
by: Rajeev Ranjan, et al.
Published: (2014-01-01)

Buprenorphine as an Efficacious Treatment for Opioid Dependency? A Survey of Counselors Attitudes
by: Agnew, Carol J.
Published: (2011)

The challenge of perioperative pain management in opioid-tolerant patients
by: Coluzzi F, et al.
Published: (2017-09-01)

Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder
by: Chappuy M, et al.
Published: (2021-06-01)

Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice
by: Johan Kakko, et al.
Published: (2019-08-01)

SR-17018 Stimulates Atypical µ-Opioid Receptor Phosphorylation and Dephosphorylation
by: Sebastian Fritzwanker, et al.
Published: (2021-07-01)

Effects of Opioid Dependence on Visuospatial Memory and Its Associations With Depression and Anxiety
by: Serenella Tolomeo, et al.
Published: (2019-10-01)

Primary care for opioid use disorder
by: Mannelli P, et al.
Published: (2016-08-01)

Potential impact of obligatory use of opioids in invasive procedures on interpretation of experimental data
by: Michał Zimecki
Published: (2018-02-01)

A novel mhealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder
by: Ochalek, Taylor A.
Published: (2018)

Rapid effect of a single-dose buprenorphine on reduction of opioid craving and suicidal ideation: A randomized, double blind, placebo-controlled study
by: Jamshid Ahmadi, et al.
Published: (2020-01-01)

Cognition and Opioid Substitution Therapy Adherence in Patients with Opioid Dependence
by: Shabina A Sheth, et al.
Published: (2018-05-01)

Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
by: K. K. Adams, et al.
Published: (2021-06-01)

Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 “optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)”
by: Matisyahu Shulman, et al.
Published: (2021-03-01)

Benefit-Risk Analysis of Buprenorphine for Pain Management
by: Hale M, et al.
Published: (2021-05-01)

Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial
by: Nasim Zamani, et al.
Published: (2020-02-01)

Associations between implementation of Project Lazarus and opioid analgesic dispensing and buprenorphine utilization in North Carolina, 2009–2014
by: Apostolos A. Alexandridis, et al.
Published: (2019-01-01)

Cannot write session to /tmp/vufind_sessions/sess_u7e89b43s55fef3tv7nvmnifvo